To prove that antagonist anti-IL-7Rα mAbs induced antigen-specific hyporesponsiveness and not broader immunodeficiency, we first assessed ex vivo polyclonal activation of baboon PBMCs before and during treatment. This evidence concerns the gene IL7R and immunodeficiency disease.